Medicine for treating idiopathic thrombocytopenic purpura

Abstract

The invention discloses medicine for treating idiopathic thrombocytopenic purpura. Scientific and reasonable compatibility is conducted on lindera aggregate, agilawood, moleplant seeds, achyranthes bidentata, ramulus euonyrni, opuntia dillenii haw, radix glycyrrhizae, astragalus membranaceus, rhizoma curculiginis, frankincense, cinnamon, herba epimedii, tuber fleeceflower stem, szechwan Chinaberry fruit, semen lepidii, Chinese polyphaga, polyporus umbellatus, fewflower wildrice fruit, radix paeoniae alba, radix ophiopogonis, prepared rehmannia root, ginger processed pinellia, caulis bambusae in taeniis, arisaema cum bile, polygala tenuifolia, semen boitae, caulis spatholobi, juncus effuses, spiderflower seed, angelica sinensis, sappanwood, pangolin, curcuma, curcuma aromatica, ligusticum wallichii, trichosanthes peel, loranthus parasiticus, codonopsis pilosula, cynanchum paniculatum, coptis chinensis, rhizoma alismatis, fiveleaf akebia fruit, uncaria, rhodiola rosea, pubescent holly root and schisandra chinensis according to the principle of monarch, minister, assistant and guide. The medicine has functions of nourishing blood and enriching blood, nourishing yin and supplementing marrow, promoting sperm production and moistening dryness, and tonifying qi and strengthening middle warmer, and has the advantages of being rapid in effect, remarkable in effect, short in treatment course, free of toxic and side effects and the like.

Description

technical field [0001] The invention relates to a medicine for treating primary thrombocytopenic purpura. Background technique [0002] Thrombocytopenic purpura is a clinical allergic and hemorrhagic disease in peripheral blood vessels. The pathogenesis of the disease is that the patient's body is stimulated by certain allergens to have an allergic reaction, which causes extensive peripheral capillary blood vessels in the patient's body. inflammation. In severe cases, necrotizing arteriolar lesions may even occur, causing the peripheral capillary wall of the patient to become brittle and its permeability increased, resulting in edema and hemorrhage of the mucous membrane, subcutaneous tissue, and internal organs. The disease can be induced by factors such as drugs, infection, and food, especially foods containing certain special proteins, such as seafood products. Pathological examination of patients with thrombocytopenic purpura shows platelet thrombus formation and focal...

AI Technical Summary

Problems solved by technology

At present, the treatment of thrombocytopenic purpura mainly includes: western medicine, platelet transfusion is the standard treatment, but due to the short storage time, lack of blood supply sources, high cost, and the possibility of blood-borne infection, blood transfusion reaction and platelet antibody production, etc. Clinical application is limited; although interleukin and thrombopoietin have good curative effects, their clinical application is also limited due to factors such as large adverse reactions and high prices, which brings a lot of inconvenience to patients